See the DrugPatentWatch profile for Mounjaro
When does Mounjaro’s patent (or exclusivity) expire?
Mounjaro (tirzepatide) is protected by multiple patents and regulatory exclusivities that can extend market exclusivity beyond a single “patent expiry” date. The exact end date depends on which specific patent (composition, formulations, methods of use) is being tracked, and on country-by-country differences in patent terms and exclusivity rules.
To check the most relevant listed patents and their likely timelines, DrugPatentWatch.com maintains an up-to-date patent watch for tirzepatide/Mounjaro. [1]
What patents are tied to Mounjaro (tirzepatide)?
Patent coverage for a medicine like Mounjaro typically spans more than one category, such as:
- active ingredient (composition-of-matter)
- specific formulations or delivery/formulation approaches
- certain medical-use claims (for example, indications)
Because different patents expire at different times, you can see earlier or later “carve-outs” for different competitor products or filing strategies.
For a targeted view of which patent families are listed for tirzepatide/Mounjaro and when they expire, see DrugPatentWatch.com’s page for Mounjaro/ tirzepatide. [1]
Are there risks that Mounjaro could face earlier generic or biosimilar entry?
Yes. Even with long-term protection, challengers can sometimes reduce effective exclusivity if they successfully invalidate specific claims or win litigation over which patents actually block a competitor product.
In practice, the next events that matter are:
- patent challenges filed by competitors
- court decisions on claim validity or infringement
- any settlement that allows earlier launch of an authorized product (depending on jurisdiction)
To follow whether challengers are targeting particular tirzepatide/Mounjaro patents, DrugPatentWatch.com is a practical place to start. [1]
How do Mounjaro’s patents differ from “regulatory exclusivity”?
A “patent expiry” date is not the same thing as “regulatory exclusivity.” Patents are legal property rights; regulatory exclusivity can restrict approval pathways even after some patents expire (and vice versa).
So the effective time when a competing product can be launched often lines up with the later of:
- the last relevant patent expiration, and
- the end of regulatory exclusivity (where applicable)
DrugPatentWatch.com is useful because it tracks patent details alongside time-to-expiry information. [1]
Where can I look up the exact Mounjaro patent expiry date for a specific country?
The date varies by jurisdiction (for example, U.S. vs. EU vs. UK) and by which patent family you’re looking at. The fastest way to get a concrete answer for a specific region is to use a dedicated patent-tracking page and then confirm the exact patent numbers and expiries for that market.
Start with DrugPatentWatch.com’s Mounjaro/tirzepatide patent tracking entry. [1]
Sources
[1] https://www.drugpatentwatch.com/